
Cialis 5mg Film-Coated Tablets - Patient Information Leaflet (PIL) - (emc)









{arrow_up} Back to top
About Medicine
{medical_services}
Prescription only medicine
My Account Area
{arrow_down}
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is an essential document that accompanies the medication package and contains crucial information.
Last updated on emc: 13 Sep 2023
CIALIS® 5 mg Film-Coated Tablets
Active ingredient: tadalafil
- Keep this leaflet handy; you may need to refer to it at any time.
- If you have further questions, please consult your healthcare provider or pharmacist.
- This medication is prescribed specifically for you. Do not share it with others, as it may cause harm to them, even if their symptoms are similar to yours.
- Inform your doctor or pharmacist of any side effects you experience, including any that are not mentioned in this leaflet. For detailed information, refer to section 4.
1. What CIALIS is and its uses
2. Important information before taking CIALIS
3. Instructions for taking CIALIS
4. Potential side effects
5. How to store CIALIS
6. Additional details regarding packaging and other information
CIALIS contains tadalafil, a drug that is classified as a phosphodiesterase type 5 inhibitor, utilized for specific therapeutic applications.
CIALIS 5 mg is indicated for adult men diagnosed with:
- Erectile dysfunction: a condition where a male is unable to achieve or maintain a firm, erect penis sufficient for sexual activity. CIALIS significantly enhances the capability to achieve an erection. Upon sexual stimulation, CIALIS promotes relaxation of the blood vessels within the penis, facilitating increased blood flow and enhancing erectile function. It is essential to note that CIALIS is ineffective without sexual stimulation, and foreplay with your partner is necessary.
- Urinary symptoms stemming from benign prostatic hyperplasia (BPH): This condition is characterized by an enlarged prostate gland with age. Symptoms may include difficulty initiating urination, the sensation of incomplete bladder emptying, and an increased frequency of urination, particularly at night. CIALIS fosters better blood circulation and muscle relaxation in the prostate and bladder, potentially alleviating the symptoms of BPH, with noticeable improvements seen as early as 1-2 weeks post initiation of treatment.
- If you are allergic to tadalafil or any other ingredients present in this medication (refer to section 6).
- If you are using any form of organic nitrates or nitric oxide donors such as amyl nitrite, which are medications prescribed for angina (chest pain). CIALIS may amplify the effects of these substances. Consult your physician if you are currently on nitrates or have any uncertainties.
- Individuals with significant heart disease or who have recently suffered a heart attack (within the past 90 days).
- Those who have experienced a stroke within the last 6 months.
- Individuals with low blood pressure or poorly controlled hypertension.
- If you have a medical history of vision loss due to non-arteritic anterior ischemic optic neuropathy (NAION).
- You should not use riociguat concurrently, as it treats pulmonary arterial hypertension and may heighten the hypotensive effects when combined with PDE5 inhibitors like CIALIS. Inform your doctor if you are taking riociguat or are unsure.
Prior to taking CIALIS, consult with your healthcare provider.
Be advised that sexual activity poses a potential risk for those with pre-existing heart conditions due to added stress on the heart. Disclosure of any heart-related issues to your physician is essential.
Given that benign prostatic hyperplasia and prostate cancer can present similar symptoms, your doctor will perform checks for prostate cancer before prescribing CIALIS for BPH treatment. Note that CIALIS does not treat prostate cancer.
Before commencing therapy, inform your physician if you have:
- Sickle cell anemia (a blood disorder).
- Multiple myeloma (a type of blood cancer).
- Leukemia (cancer affecting blood cells).
- Any structural deformities of the penis.
- Severe liver impairment.
- Severe renal impairment.
The efficacy of CIALIS in patients who have undergone:
- Pelvic surgery.
- Radical non-nerve-sparing prostatectomy (partial or complete removal of the prostate where nerves are also cut).
If you experience sudden vision loss or distorted vision while on CIALIS, cease use immediately and contact your healthcare provider without delay.
Some patients on tadalafil have reported sudden hearing loss. Although causation remains unclear, should you experience such symptoms, discontinuation is warranted and consult your doctor promptly.
CIALIS is not approved for use in women.
CIALIS is contraindicated for children and adolescents under 18 years of age.
Notify your healthcare provider if you are currently taking, have recently taken, or anticipate taking any other medications.
CIALIS should not be taken if you are already on nitrates.
Be aware that certain drugs may interact with CIALIS or potentially affect its efficacy. Inform your healthcare professional or pharmacist if you are currently taking:
- Alpha blockers (used for treating high blood pressure or urinary issues tied to BPH).
- Other antihypertensive medications.
- Riociguat.
- 5-alpha reductase inhibitors (for BPH treatment).
- Antifungal medications, such as ketoconazole, and protease inhibitors for HIV treatment.
- Anticonvulsants like phenobarbital, phenytoin, or carbamazepine.
- Antibiotics like rifampicin, erythromycin, or clarithromycin, and antifungals such as itraconazole.
- Other erectile dysfunction medications.
For information regarding the impact of alcohol, please refer to section 3. Grapefruit juice may alter the functionality of CIALIS and should be consumed with care. Consult your physician for further details.
Research on animals has shown that treatment may result in reduced sperm production in the testes. Among some males, a decrease in sperm count has been noted, although these effects are unlikely to result in infertility.
Dizziness has been reported by some males in clinical studies involving CIALIS. It is recommended to assess your reaction to the medication before engaging in activities requiring mental alertness, such as driving or operating machinery.
If your doctor has indicated an intolerance to certain sugars, please consult your healthcare provider before using this medication.
This medication contains less than 1 mmol sodium (23 mg) per tablet, essentially rendering it ‘sodium-free’.
Always adhere to the prescribed dosage regimen as indicated by your healthcare professional. For any uncertainties, consult with your doctor or pharmacist.
CIALIS tablets are intended for oral consumption by males exclusively. Swallow the tablet whole with water. These tablets can be ingested with or without food.
Alcohol consumption may lead to a transient decrease in blood pressure. If you plan to consume CIALIS, refrain from excessive drinking (blood alcohol level of 0.08% or higher), as this may raise the likelihood of dizziness when standing.
The recommended dose is a single 5 mg tablet taken once daily, ideally at the same time each day. Based on your response, your physician may adjust the dose to 2.5 mg, which will be provided as a 2.5 mg tablet.
Do not take more than one dose of CIALIS within 24 hours.
With a regimen of once daily dosing, CIALIS allows you to achieve an erection upon sexual stimulation any time within 24 hours. This regimen may be advantageous for men anticipating sexual activity two or more times a week.
It is important to emphasize that CIALIS will not be effective without sexual stimulation. Foreplay with your partner remains essential as if you were not utilizing any erectile dysfunction medication.
Excessive alcohol consumption can negatively impact your ability to achieve an erection.
The dose is one tablet of 5 mg taken once daily at around the same time each day.
For men with concurrent benign prostatic hyperplasia and erectile dysfunction, the dosage remains at one tablet of 5 mg once daily.
Do not exceed one tablet of CIALIS within a single day.
Consult your physician. Be vigilant for possible side effects as detailed in section 4.
Should you forget a dose, take it as soon as you remember but refrain from doubling up on a missed tablet. Do not exceed one dose of CIALIS within a day.
If you have further inquiries regarding this medication, please reach out to your healthcare provider or pharmacist.
As with all medications, CIALIS may induce side effects, although not every individual will experience them. Generally, these effects are mild to moderate.
- Allergic reactions including rashes (occurrence is uncommon).
- Chest pain—seek immediate medical help and do not use nitrates (occurrence is uncommon).
- Risk of priapism, characterized by an abnormally prolonged and painful erection after CIALIS intake (occurrence is rare). Should an erection persist for over 4 hours, consult a medical professional without delay.
- Reports of sudden vision loss (occurrence is rare), along with symptoms like distorted, dimmed, and blurred central vision may occur (frequency not established).
Other side effects may include:
Common (observed in 1 to 10 out of every 100 patients)
- Headaches, back pain, muscle discomfort, pain in the extremities, facial flushing, nasal congestion, and dyspepsia.
Uncommon (noted in 1 to 10 out of every 1,000 patients)
- Dizziness, abdominal pain, nausea, vomiting, acid reflux, visual disturbances, eye discomfort, breathing difficulties, blood in urine, prolonged erection, palpitations, tachycardia, hypertension, hypotension, epistaxis, tinnitus, swelling in extremities, and fatigue.
Rare (seen in 1 to 10 out of every 10,000 patients)
- Fainting, seizures, transient memory loss episodes, eyelid edema, conjunctival injection, sudden hearing loss, urticaria (itchy welts), penile bleeding, blood in semen, and increased perspiration.
Cardiovascular events such as heart attacks and strokes have also been rarely documented in patients taking CIALIS, predominantly among those with pre-existing heart conditions.
Instances of partial, temporary, or permanent loss of vision in one or both eyes have been infrequently reported.
Some additional rare side effects have been observed in males using CIALIS, which were not identified in clinical trials. These include:
- Migraine, facial edema, severe allergic reactions with facial or throat swelling, significant dermal rashes, disruptions in ocular blood circulation, arrhythmias, chest pain, and, in extreme cases, sudden cardiac death.
- Visual disturbances such as blurred or dimmed vision (frequency not established).
The occurrence of dizziness was found more prevalent among men over the age of 75 who were taking CIALIS, while diarrhea was reported more frequently in those over 65.
If you experience any side effects, please communicate with your healthcare provider or pharmacist. This includes any side effects not cited within this leaflet. You may also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard, or search for the MHRA Yellow Card application in the Google Play or Apple App Store.
Ensure that this medication is stored in a location inaccessible to children.
Do not utilize this medicine after the expiration date indicated on the carton and blister, post ‘EXP’. The expiration date applies to the final day of that particular month.
Keep in the original packaging to safeguard against moisture. Avoid storage above 25°C.
Never dispose of medications via wastewater or household refuse. Inquire with your pharmacist regarding appropriate disposal methods for unused medicines. These actions will contribute to environmental preservation.
- The active ingredient is tadalafil, with each tablet containing 5 mg of this compound.
- The other constituents include:
Tablet core: lactose monohydrate (see section 2), croscarmellose sodium, hydroxypropylcellulose, microcrystalline cellulose, sodium laurilsulfate, magnesium stearate, and refer to section 2 for information on lactose.
Film-coat: lactose monohydrate, hypromellose, triacetin, titanium dioxide (E171), iron oxide yellow (E172), and talc.
CIALIS 5 mg is characterized as a light yellow, almond-shaped film-coated tablet imprinted with "C 5" on one side.
This medication is available in blister packs containing 14, 28, or 84 tablets.
Availability of pack sizes may vary based on market conditions.
Marketing Authorisation Holder:
Eli Lilly Nederland B.V.
Papendorpseweg 83
3528 BJ Utrecht
The Netherlands
Manufacturer:
Lilly S.A.
Avda. de la Industria 30
28108 Alcobendas
Madrid
Spain
For any inquiries concerning this medication, contact the local representative of the Marketing Authorisation Holder:
United Kingdom (Great Britain)
Eli Lilly and Company Limited
Tel: + 44-(0) 1256 315000
This leaflet was last revised in August 2023.
CI047